Albemarle Has Executed Through Downturn, Now Positioning For Recovery, BofA Says

MT Newswires Live02-17

Albemarle (ALB) has executed through the downturn and is positioning for recovery, with the company now showing "improving" structural fundamentals, BofA Securities said in a Tuesday research note.

BofA said that the company delivered fiscal 2025 cost savings of $450 million and is guiding to a further $100 million to $150 million of incremental cost and productivity improvements, supporting its 2026 earnings before interest, taxes, depreciation and amortization guidance of $2.4 billion to $2.6 billion, versus consensus of $1.7 billion.

Additionally, the current lithium pricing supports profitable production across most of Albemarle's existing and planned portfolio, excluding Kemerton, improving confidence in earnings visibility, BofA said.

BofA raised its fiscal 2026 EBITDA estimate to $2.43 billion from $2.31 billion, on account of higher realized lithium pricing assumptions into H1 and progress on cost and productivity initiatives.

BofA upgraded its rating on Albemarle to buy from neutral and its price target to $190 from $167.

Price: 167.88, Change: +1.53, Percent Change: +0.92

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment